SK285222B6 - Spôsob výroby 2,5-diamino-4,6-dihalogénpyrimidínu - Google Patents
Spôsob výroby 2,5-diamino-4,6-dihalogénpyrimidínu Download PDFInfo
- Publication number
- SK285222B6 SK285222B6 SK683-2003A SK6832003A SK285222B6 SK 285222 B6 SK285222 B6 SK 285222B6 SK 6832003 A SK6832003 A SK 6832003A SK 285222 B6 SK285222 B6 SK 285222B6
- Authority
- SK
- Slovakia
- Prior art keywords
- diamino
- halogenated
- preparation
- process according
- dihydroxypyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98124188 | 1998-12-21 | ||
EP99100788 | 1999-01-18 | ||
EP99107161 | 1999-04-12 | ||
US14610699P | 1999-07-29 | 1999-07-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
SK285222B6 true SK285222B6 (sk) | 2006-09-07 |
Family
ID=27443679
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK683-2003A SK285222B6 (sk) | 1998-12-21 | 1999-12-16 | Spôsob výroby 2,5-diamino-4,6-dihalogénpyrimidínu |
SK1784-99A SK283681B6 (sk) | 1998-12-21 | 1999-12-16 | Spôsob výroby N-(amino-4,6-dihalogénpyrimidín)formamidov |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1784-99A SK283681B6 (sk) | 1998-12-21 | 1999-12-16 | Spôsob výroby N-(amino-4,6-dihalogénpyrimidín)formamidov |
Country Status (16)
Country | Link |
---|---|
US (2) | US6271376B1 (xx) |
EP (2) | EP1188750B1 (xx) |
JP (1) | JP3543709B2 (xx) |
KR (1) | KR100645270B1 (xx) |
CN (1) | CN1156449C (xx) |
AT (2) | ATE252087T1 (xx) |
CA (1) | CA2293011C (xx) |
CZ (2) | CZ296832B6 (xx) |
DE (2) | DE59903535D1 (xx) |
DK (1) | DK1013647T3 (xx) |
ES (2) | ES2204798T3 (xx) |
HU (1) | HUP9904608A3 (xx) |
NO (1) | NO313878B1 (xx) |
PL (1) | PL337354A1 (xx) |
PT (1) | PT1013647E (xx) |
SK (2) | SK285222B6 (xx) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7208011B2 (en) * | 2001-08-20 | 2007-04-24 | Conor Medsystems, Inc. | Implantable medical device with drug filled holes |
US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US7208010B2 (en) * | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
GB2344550A (en) * | 1998-12-09 | 2000-06-14 | Ibm | Pad design for electronic package |
EP1498084B1 (en) | 2000-10-16 | 2014-06-18 | Innovational Holdings, LLC | Expandable medical device for delivery of beneficial agent |
US20040204756A1 (en) * | 2004-02-11 | 2004-10-14 | Diaz Stephen Hunter | Absorbent article with improved liquid acquisition capacity |
US20040249443A1 (en) * | 2001-08-20 | 2004-12-09 | Shanley John F. | Expandable medical device for treating cardiac arrhythmias |
US7056338B2 (en) * | 2003-03-28 | 2006-06-06 | Conor Medsystems, Inc. | Therapeutic agent delivery device with controlled therapeutic agent release rates |
NZ536308A (en) * | 2002-05-24 | 2009-01-31 | Angiotech Int Ag | Compositions and methods for coating medical implants |
US20040142014A1 (en) * | 2002-11-08 | 2004-07-22 | Conor Medsystems, Inc. | Method and apparatus for reducing tissue damage after ischemic injury |
US20040143321A1 (en) * | 2002-11-08 | 2004-07-22 | Conor Medsystems, Inc. | Expandable medical device and method for treating chronic total occlusions with local delivery of an angiogenic factor |
WO2004043511A1 (en) * | 2002-11-08 | 2004-05-27 | Conor Medsystems, Inc. | Method and apparatus for treating vulnerable artherosclerotic plaque |
FR2849030A1 (fr) * | 2002-12-20 | 2004-06-25 | Isochem Sa | Procede de preparation des n-(2-amino-4, 6-dihalogenopyrimidin-5-yl) formamides |
WO2004087214A1 (en) | 2003-03-28 | 2004-10-14 | Conor Medsystems, Inc. | Implantable medical device with beneficial agent concentration gradient |
US20050010170A1 (en) * | 2004-02-11 | 2005-01-13 | Shanley John F | Implantable medical device with beneficial agent concentration gradient |
US20040202692A1 (en) * | 2003-03-28 | 2004-10-14 | Conor Medsystems, Inc. | Implantable medical device and method for in situ selective modulation of agent delivery |
JPWO2004103979A1 (ja) * | 2003-05-26 | 2006-07-20 | 住友化学株式会社 | N−(2−アミノ−4,6−ジクロロピリミジン−5−イル)ホルムアミドの製造方法 |
US7208596B2 (en) * | 2003-11-25 | 2007-04-24 | Bristol-Myers Squibb Pharma Company | Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof |
US20050287287A1 (en) * | 2004-06-24 | 2005-12-29 | Parker Theodore L | Methods and systems for loading an implantable medical device with beneficial agent |
CN101003511B (zh) * | 2007-01-19 | 2010-06-09 | 中国科学院上海有机化学研究所 | 制备2-氨基-4,6-二氯-5-甲酰氨基嘧啶的方法 |
CZ305457B6 (cs) * | 2011-02-28 | 2015-09-30 | Ústav organické chemie a biochemie, Akademie věd ČR v. v. i. | Pyrimidinové sloučeniny inhibující tvorbu oxidu dusnatého a prostaglandinu E2, způsob výroby a použití |
WO2014023681A1 (en) * | 2012-08-06 | 2014-02-13 | Enantia, S.L. | A process for the preparation of an intermediate for a triazolopyrimidine carbonucleoside |
CN103936681B (zh) * | 2014-04-04 | 2015-07-29 | 苏州开元民生科技股份有限公司 | 2-氨基-4,6-二氯-5-甲酰胺基嘧啶的制备方法 |
CN115536595B (zh) * | 2022-11-29 | 2023-03-10 | 苏州开元民生科技股份有限公司 | 一种2-氨基-4,6-二氯-5-甲酰胺基嘧啶的合成方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3445293A1 (de) * | 1984-12-12 | 1986-06-12 | Bayer Ag, 5090 Leverkusen | Neue 2,4-diaminopyrimidine |
US4965270A (en) * | 1987-05-30 | 1990-10-23 | Beecham Group P.L.C. | Purine derivatives |
CN1019575B (zh) * | 1988-02-19 | 1992-12-23 | 石原产业株式会社 | 2-氨基-4,6-二氯嘧啶的生产方法 |
DE3900471A1 (de) * | 1989-01-10 | 1990-07-12 | Basf Ag | Verfahren zur herstellung von 2-amino-4-fluorpyrimidinderivaten |
GB8916698D0 (en) * | 1989-07-21 | 1989-09-06 | Beecham Group Plc | Novel process |
CZ287049B6 (cs) * | 1992-01-22 | 2000-08-16 | Lonza A. G. | N-5-chráněné 2,5-diamino-4,6-dichlorpyrimidiny a způsob jejich přípravy |
GB9402161D0 (en) * | 1994-02-04 | 1994-03-30 | Wellcome Found | Chloropyrimidine intermediates |
CA2145928C (en) * | 1994-04-27 | 2007-10-09 | Gerhard Stucky | N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide, and a process for its preparation |
AT402924B (de) * | 1994-05-13 | 1997-09-25 | Chemie Linz Gmbh | Verfahren zur herstellung von 2-amino-4,6-dichloro-pyrimidin |
-
1999
- 1999-12-15 ES ES01130001T patent/ES2204798T3/es not_active Expired - Lifetime
- 1999-12-15 PT PT99125042T patent/PT1013647E/pt unknown
- 1999-12-15 DK DK99125042T patent/DK1013647T3/da active
- 1999-12-15 DE DE59903535T patent/DE59903535D1/de not_active Expired - Fee Related
- 1999-12-15 AT AT01130001T patent/ATE252087T1/de not_active IP Right Cessation
- 1999-12-15 EP EP01130001A patent/EP1188750B1/de not_active Expired - Lifetime
- 1999-12-15 DE DE59907401T patent/DE59907401D1/de not_active Expired - Fee Related
- 1999-12-15 EP EP99125042A patent/EP1013647B1/de not_active Expired - Lifetime
- 1999-12-15 AT AT99125042T patent/ATE228508T1/de not_active IP Right Cessation
- 1999-12-15 ES ES99125042T patent/ES2187112T3/es not_active Expired - Lifetime
- 1999-12-16 SK SK683-2003A patent/SK285222B6/sk not_active IP Right Cessation
- 1999-12-16 HU HU9904608A patent/HUP9904608A3/hu unknown
- 1999-12-16 SK SK1784-99A patent/SK283681B6/sk not_active IP Right Cessation
- 1999-12-16 US US09/461,244 patent/US6271376B1/en not_active Expired - Fee Related
- 1999-12-17 CZ CZ20050024A patent/CZ296832B6/cs not_active IP Right Cessation
- 1999-12-17 CZ CZ0459899A patent/CZ296753B6/cs not_active IP Right Cessation
- 1999-12-17 CN CNB991262441A patent/CN1156449C/zh not_active Expired - Fee Related
- 1999-12-17 JP JP35977899A patent/JP3543709B2/ja not_active Expired - Fee Related
- 1999-12-20 NO NO19996325A patent/NO313878B1/no not_active IP Right Cessation
- 1999-12-21 PL PL99337354A patent/PL337354A1/xx not_active IP Right Cessation
- 1999-12-21 CA CA002293011A patent/CA2293011C/en not_active Expired - Fee Related
- 1999-12-21 KR KR1019990059846A patent/KR100645270B1/ko not_active IP Right Cessation
-
2001
- 2001-05-31 US US09/867,552 patent/US6716981B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK285222B6 (sk) | Spôsob výroby 2,5-diamino-4,6-dihalogénpyrimidínu | |
ES2389565T3 (es) | Rosuvastatina y sales de la misma carentes de alquiléter de rosuvatatina y un procedimiento para la preparación de las mismas | |
KR20180015142A (ko) | 키나아제를 조절하는 1h-피롤로[2,3b]피리딘 유도체의 합성 | |
US9676803B2 (en) | Efficient process for separation of diastereomers of 9-[(R)-2-[[(R,S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl]methoxy]propyl]adenine | |
JP3688295B2 (ja) | 4,6−ジクロロピリミジンの製造方法 | |
WO2014027330A1 (en) | Process for the preparation of|(2z,5z)-5-(3-chloro-4-((r)-2,3-dihydroxypropoxy)benzylidene)-2-(propylimino)-3-|(o-tolyl)thiazolidin-4-one and intermediate used in said process | |
CA2848631A1 (en) | Rilpivirine hydrochloride | |
US5216161A (en) | Process for preparing 2,5-diamino-4,6-dichloropyrimidine | |
Hirokami et al. | Photochemical reactions of 4-pyrimidones. Structures and properties of the. beta.-lactams formed | |
Pilyo et al. | A combinatorial library of substituted 3-sulfonyl-2-imino-1, 2-dihydro-5H-dipyrido [1, 2-a: 2', 3'-d] pyrimidin-5-ones and their anticancer activities. | |
EP2057166B1 (en) | Process and intermediates for the synthesis of (3-alkyl-5-piperidin-1-yl-3,3a-dihydropyrazolo[1,5-a]pyrimidin-7-yl)-amino derivatives | |
Xia et al. | A convenient synthesis of N, N, N'-trisubstituted ethylenediamine derivatives from 2-methyl-2-imidazoline | |
US4568744A (en) | Benzylpyrimidine synthesis and intermediates | |
KR100411400B1 (ko) | 화학적방법 | |
JP2657150B2 (ja) | ベンジルピリミジン誘導体 | |
HU189253B (en) | Process for preparing 2-pyridyl-alkyl-amine derivatives | |
NO300547B1 (no) | Fremgangsmåte for fremstilling av en metandifosfonatforbindelse | |
PL55444B1 (xx) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20091216 |